Sun Pharma reports strong quarter

Net Sales Rs.3482 crores, up 31%, Adjusted Net Profit Rs.1241 crores, up 56%


Sun Pharmaceutical Industries Ltd. reported financials for the first quarter ending June, 2013.

Dilip Shanghvi, Managing Director of the Company said, "All our businesses continue to perform in-line with our expectations.We remain focused on strengthening our existing businesses and developing a differentiated and speciality driven product basket. We also continue to review opportunities to expand and strengthen our global footprint."

Highlights of Q1FY14 consolidated financials:

- Branded generic sales in India, at Rs. 849 crores, grew by 44% over Q1 last year. Adjusted sales growth of the domestic formulation business.

- US finished dosages sale is US$ 364 million recording a growth of 28% over Q1 last year.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email